Summary Remaining lifetime and absolute 10-year probabilities for osteoporotic fractures were determined by gender, age, and BMD values. Remaining lifetime probability at age 50 years was 20.2% in men and 51.3% in women and increased with advancing age and decreasing BMD. The study validates the elements required to populate a Swiss-specific FRAX® model. Introduction Switzerland belongs to high-risk countries for osteoporosis. Based on demographic projections, burden will still increase. We assessed remaining lifetime and absolute 10-year probabilities for osteoporotic fractures by gender, age and BMD in order to populate FRAX® algorithm for Switzerland. Methods Osteoporotic fracture incidence was determined from national epidemiological data for hospitalised fractured patients from the Swiss Federal Office of Statistics in 2000 and results of a prospective Swiss cohort with almost 5,000 fractured patients in 2006. Validated BMDassociated fracture risk was used together with national death incidence and risk tables to determine remaining lifetime and absolute 10-year fracture probabilities for hip and major osteoporotic (hip, spine, distal radius, proximal humerus) fractures. Results Major osteoporotic fractures incidence was 773 and 2,078 per 100,000 men and women aged 50 and older. Corresponding remaining lifetime probabilities at age 50 were 20.2% and 51.3%. Hospitalisation for clinical spine, distal radius, and proximal humerus fractures reached 25%, 30% and 50%, respectively. Absolute 10-year probability of osteoporotic fracture increased with advancing age and decreasing BMD and was higher in women than in men. Conclusion This study validates the elements required to populate a Swiss-specific FRAX® model, a country at highest risk for osteoporotic fractures.
Introduction
The World Health Organization (WHO) defined osteoporosis as "a systemic skeletal disease characterised by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture" [1] . The most frequent complications of the disease are the "typical" osteoporotic fractures occurring at the hip, spine, distal forearm and proximal humerus. Furthermore, the WHO proposed an operational definition of osteoporosis as a bone mineral density (BMD) that lies 2.5 standard deviations or more below the average mean value of young healthy women (T score≤−2.5 SD) [1, 2] . Until recently and based on the latter definition, fracture risk was commonly expressed as the relative risk of sustaining an osteoporotic fracture compared to the gendermatched risk of the general population [3] . In the presence of osteoporosis, the relative risk of osteoporotic fracture at any age was shown to decrease with advancing age, albeit that the absolute risk was continuously increasing, which led to the conclusion that, for clinical use, absolute risks may be preferred to relative risks [3] . Since then, the determination of 10-year probability of fracture has increasingly gained acceptance [4] [5] [6] [7] [8] [9] [10] [11] . Gender, age, and BMD belong to the strongest predictors of osteoporotic fracture risk, and their combination with other clinical risk factors has been shown to improve the specificity and sensitivity of fracture risk prediction at the individual patient level [12] . Recently, a fracture risk assessment tool (FRAX®) supported by the WHO [13] was developed based on the use of clinical risk factors with or without BMD for several countries, including the UK [4] , US [14] and Japan [11] .
One of the key requirements for the development of FRAX® is the availability of country specific fracture outcome and mortality data. Although the epidemiology of hospitalised osteoporotic and non-osteoporotic fractures in Switzerland in year 2000 was previously published [15] , the absolute 10-year and the remaining lifetime fracture probabilities for an osteoporosis-related fracture are not known.
The aim of the present study was to determine the absolute 10-year and remaining lifetime fracture probabilities by gender, age and BMD categories for the Swiss population for future FRAX® modelling.
Methods
The incidence of hospitalisation for fractures and osteoporotic fractures by gender, age group, and fracture type in year 2000 have been previously published based on the administrative and medical and population structure statistics of the Swiss Federal Office of Statistics (SFOS) [15] . For the present analysis, the incidence by gender and 5-year age groups starting at age 50 were used for the following osteoporosisrelated fracture sites: hip (ICD-10 codes S72.0 (fracture of the femoral neck), S72.1 (pertrochanteric fracture) and S72.2 (subtrochanteric fracture)); spine (S22.0 (fracture of the thoracic spine), S22.1 (multiple fractures of the thoracic spine), S32.0 (fracture of the lumbar spine), S32.7 (multiple fractures of the lumbar spine) and S32.8 (other fractures of the lumbar spine)); distal radius (S52.5 (fracture of the distal radius) and S52.6 (combined fracture of the distal radius/ ulna)); and proximal humerus (S42.2, fracture of the proximal humerus). These previously published data represented only hospitalised clinical fractures.
In order to determine the total number of fractures (hospitalised and non-hospitalised) at these osteoporosisrelated sites, additional data from the Swiss OsteoCare survey were used [16] . Briefly, the OsteoCare nationwide survey aimed at assessing the quality level of osteoporosis management in patients aged 50 years or older presenting with a clinical fracture at the emergency ward of the participating hospitals in Switzerland. In total, 4,966 consecutive men (N=1,368, mean age 69.0 years) and women (N=3,598, mean age 73.9 years) with any clinical fracture were recruited in eight centres between 2004 and 2006 during a mean duration of observation of 12.2 months. For each patient, a predefined standardised questionnaire was used in all centres to characterise the current acute clinical fracture event. Of all hospitalised and nonhospitalised fractures reported, those categorised as hip (pertrochanteric and femoral neck), spine (lumbar or thoracic), distal forearm and proximal humerus fractures were used for the present analysis. Two hundred ninety-five and 881 hip fractures were reported in the survey for men and women, respectively. On the other hand, 2,506 and 8,074 hip fractures were reported as hospitalised in the medical database of the SFOS. Therefore, the ratio between the number of hip fractures in the OsteoCare cohort and the number of hospitalised fractures published earlier was 8.49 (2,506/295) in men and 9.16 (8,074/881) in women. Assuming that all hip fractures of the OsteoCare cohort were hospitalised, this ratio was applied as a genderspecific multiplier to the number of spine, distal radius and proximal humerus fractures by 5-year age groups in the OsteoCare cohort to determine the expected total (hospitalised and non-hospitalised) number of fractures and their corresponding incidence by gender and 5-year age group, i.e. the expected number of fractures which would have occurred at each predefined site if all fractures (hospitalised and non-hospitalised) had been registered in the previously published cohort. Furthermore, the ratio between the number of hospitalised spine, distal radius and proximal humerus fractures reported by the SFOS and the expected number of these fractures resulting from extrapolation of the OsteoCare cohort were used to quantify the fracturesite-specific hospitalisation rate by gender and 5-year age group.
Thereafter, the remaining lifetime and absolute 10-year probabilities for osteoporosis-related clinical fractures were calculated by gender and 5-year age groups by applying the death risk and incidence tables for Switzerland in 1999 published by the WHO [17] . Finally, BMD and fracture risk categories, expressed in 0.5 T-score steps at the femoral neck, taken from a previously published analysis of ten populationbased cohorts [7] , were applied to the absolute 10-year and residual lifetime probability tables. For the following tables, the T scores shown represent the BMD value at the beginning of the measurement period, derived from the NHANES III data for Caucasian women aged 20-29 years for BMD at the femoral neck [18] , including men and as widely recommended [19] .
The calculation flow and the datasets successively used to determine the residual lifetime and 10-year probabilities of osteoporosis-related fractures in Switzerland are shown in Fig. 1 . For this analysis, it was assumed that (1) all hip fractures were hospitalized, which is consistent with the findings in the Swiss OsteoCare cohort [16] ; (2) as all hip fractures were hospitalised, the same ratio could be used across age groups for extrapolating the cohort results to determine the total number of expected osteoporosis-related fractures as long as it remained gender specific; (3) the hospitalisation rate for fractures reported in OsteoCare [16] is the same as for the fractures reported by the SFOS [15] ; (4) the BMD distribution is similar to that of US NHANES III cohort [7, 18] ; and (5) the BMD gradient of risk is the same as reported in the population-based cohorts used for the FRAX® algorithm [7] .
All calculations were made by gender, osteoporosis-related clinical fracture type and 5-year age groups.
Results
In Switzerland, in year 2000, the selected osteoporosis-related fracture sites (hip, spine, distal radius and proximal humerus) represented 63.1% (4,085/6,470) and 75.5% (13, Table 1 .
Hospitalisation rates
Except for hip fractures, where the hospitalisation rate was assumed to be 100%, fractures of the proximal humerus were hospitalised in almost 50% of men and more than 50% of women. Approximately one third of all distal radius fractures and one fourth of all clinical spine fractures were hospitalised in both men and women. The hospitalisation rates were generally higher in the younger (50-59 years) and older (85+) age segments as shown in Table 2 .
Remaining lifetime probability Overall, the remaining lifetime probability for any osteoporosis-related fracture in Switzerland was 20.2% and 51.3% for a 50-year old man and woman, respectively (Table 3) . Remaining lifetime probability of any major osteoporosis-related fracture increased with advancing age and with decreasing BMD T-score values at the femoral neck and was always higher in women than in men (Table 4) . However, lower T-score values increased remaining lifetime probability far more than increasing age. For example, in a 50 year-old woman, decreasing femoral neck T-score values from + 1.0 to −4.0 SD with the normative database of NHANES III were accompanied by an increase in remaining lifetime probability for hip fracture from 5.2% to 70.2% (+65% absolute increase). In comparison, an increase from age 50 to age 85+ years, at a given T score of −2.5 SD, was accompanied by an increase from 45.1% to 48.4% (+3.3% absolute increase) in remaining lifetime probability for hip fracture in women. Similar observations apply to men and to the remaining lifetime probability for any osteoporotic fracture.
Absolute 10-year probability of osteoporotic fracture
At any age, the absolute 10-year probability for hip fracture or any osteoporotic fracture increased with advancing age and was higher in women than in men as shown in Table 3 .
In men, the 10-year fracture probability for hip fracture and any osteoporotic fracture increased from 0.6% at age 50 to 7.4% at age 85+ and from 4.1% at age 50 to 12.7% at age 85+, respectively. In women, the corresponding increases were from 0.5% to 20.4% and from 6.1% to 33.0%, respectively ( Table 3 ). The addition of the third parameter, femoral neck T-score, allowed for a refined risk categorisation and for the identification of individual absolute 10-year fracture probabilities up to 45.1% for hip fracture and 66.9% for any osteoporotic fracture in women, with corresponding risk levels up to 26.9% and 38.7% in men (Figs. 2 and 3). As already observed for the remaining lifetime probability of fracture, the increase in 10-year fracture probability was steeper with decreasing BMD than with increasing age in both genders, albeit less pronounced. In men, 10-year lifetime risk Based on Swiss fracture data from the SFOS [15] and the Swiss OsteoCare cohort [16] progression with age flattened or decreased for the older age group as a result of increasing competition of other causes of death.
Discussion
The present analysis reports the incidence, the remaining lifetime probability and the 10-year absolute probability of suffering from one of the major osteoporotic fractures in men and women living in Switzerland. The reported incidences of any (hospitalised or nonhospitalised) major osteoporotic fracture (hip, spine, distal radius and proximal humerus) are higher than previously thought [20, 21] . With regard to hip fractures alone, Sweden and the USA (Caucasians) are typically considered as very high risk; UK and Italy are considered as high-risk countries [20] . As shown in Fig. 4 and depending on the age group considered, the incidence of the major osteoporotic fractures in Switzerland was similar to that of the very high-risk countries or at least at the high end of the high-risk countries [21] . In the present study, the global incidence of the selected osteoporosis-related fractures was calculated by deriving the percentage of hospitalised fractures from a Swiss cohort of 4,966 consecutive patients, aged 50 years or older, who presented with a clinical fracture at the emergency ward, seeking medical care. The hospitalisation rates of the non-hip fractures were derived by assuming that hip fractures were always hospitalised, i.e. that they would allow for a correction of the cohort size by applying a gender-specific correction factor to the previously published data of hospitalised fractures. The calculated hospitalisation rates for the major osteoporotic fractures (Table 2) are lower than the overall hospitalisation rate after fracture in the OsteoCare cohort, in which 80.2% of the patients were hospitalised [16] . However, this percentage most certainly reflects a selection bias due to the fact that the survey was limited to patients seeking medical care at a hospital emergency ward. Therefore, and for the first time, by combining fracture hospitalisation data and clinical fracture incidence data, the present analysis provides an estimate of the proportion of patients treated as out-patients after a clinical spine, distal radius and proximal humerus fracture and leads to fracture incidences comparable or higher than those reported for Sweden [22, 23] . Furthermore, approximately one third of all osteoporotic fractures occurring in men and one fourth of those in women were not considered in the present analysis, which leads to an underestimation of fracture risk. On the Table 3 Overall remaining lifetime probability (percent) for an osteoporosis-related fracture at age 50 years and absolute 10-year osteoporosisrelated fracture probability (percent) at ages shown Fracture site Gender Remaining lifetime probability at age 50 (%) 10 year probability of fracture at age x (%) Based on Swiss fracture data from the SFOS [15] , the Swiss OsteoCare cohort [16] , death risk and incidence tables for Switzerland published by the WHO [17] , BMD gradients of risk determined in ten international population-based cohorts [7] validated for Switzerland [12] and BMD normative data from US NHANES III [18] other hand, the cohorts used did not allow for a differentiation between first and subsequent fractures. As a prior history of fragility fracture increases the risk for subsequent fractures [12, 20, 24] , this might have led to an overestimation of the individual fracture risk based on the three characteristics of gender, age and BMD only. Switzerland belongs to the countries with the highest life expectancy at birth worldwide (76.7 years for men and 82.5 years for women in 2001) [25] and a stronger increase in the number of nonagenarians and centenarians than in other countries was recently reported, mostly attributable to the decline in mortality after the age of 80 years, which had started already in the 1950s [26] . For this reason, Switzerland ranks second worldwide after Japan with regard to the number of elderly in the resident population [26] . Furthermore, the recent demographic scenarios projecting the aging of the population in Switzerland between 2005 and 2050 [27] showed that this increasing trend will not leveloff before year 2050, leading to almost a doubling of the population older than 65 years of age by that date (Fig. 5 ). Based on current trends and on age distribution alone, Switzerland can therefore be expected to become the European country exposed earliest to the massive impact of the societal and economic consequences of an increasing number of osteoporotic fractures and may be considered as a paradigm for the unfortunate future of most other European countries.
Based on the present results, in Switzerland, one out of five 50-year-old men and one out of two 50-year-old women will suffer from at least one clinical fracture of the hip, the spine, the distal radius and/or the proximal humerus during their remaining lifetime. These figures are consistent Women 10-year absolute probability of any osteoporotic fracture Fig. 3 Absolute 10-year probability for a major osteoporotic fracture (hip, clinical spine, distal radius or proximal humerus; percent) by gender, age and femoral neck T score. Based on Swiss fracture data from the SFOS [15] , the Swiss OsteoCare cohort [16] , death risk and incidence tables for Switzerland published by the WHO [17] , BMD gradients of risk determined in ten international population-based cohorts [7] validated for Switzerland [12] and BMD normative data from US NHANES III [18] Women 10-year absolute probability of hip fracture Fig. 2 Absolute 10-year probability of hip fracture (percent) by gender, age and femoral neck T score. Based on Swiss fracture data from the SFOS [15] , the Swiss OsteoCare cohort [16] , death risk and incidence tables for Switzerland published by the WHO [17] , BMD gradients of risk determined in ten international population-based cohorts [7] validated for Switzerland [12] and BMD normative data from US NHANES III [18] with the estimated long-term risk for any of these osteoporotic fractures in Malmö, Sweden of 23.8% and 47.3% in 45-year-old men and women, respectively [23] . They are also consistent with earlier findings from the population-based Study of Osteoporotic Fractures in the USA, according to which a 50-year-old white woman had a 16% risk of suffering a hip fracture, a 15% risk of suffering a radius fracture and a 32% risk of sustaining a vertebral fracture during her remaining lifetime [28] and with recent results from the Australian Dubbo study, which showed a remaining lifetime probability for any low-trauma nonpathological fracture at age 60 of 25% in men and 44% in women, respectively, after adjustment for competing risk of death [29] . These remaining lifetime probabilities can also be compared to other diseases such as atherosclerotic cardiovascular disease (myocardial infarction, coronary insufficiency, angina, stroke and claudication) with a lifetime risk at age 50 years of 51.7% for men and 39.2% for women [30] ; clinical stroke, lifetime risk at age 65 years of 14.5% for men and 16.1% for women [31] ; congestive heart failure, lifetime risk at age 40 years of 21.0% for men and 20.3% for women [32] ; and cancer, lifetime risk at birth of being diagnosed with any cancer of 44.9% in men and 37.5% in women [33] .
The concept of absolute fracture risk accommodates for the background prevalence of a disease, a clinically relevant dimension, which is lost when using relative risks. In other words, for two distinct diseases with identical relative risks, the absolute risk will be higher for the disease with the highest prevalence. Furthermore, absolute fracture risk reporting is preferred to the traditional T-score reporting by Canadian physicians, non-specialist physicians being particularly supportive of risk-based BMD reporting [34] , and is being increasingly adopted in clinical guidelines [35] [36] [37] [38] [39] and for the development of new drugs [40] . It is therefore reasonable to assume that an absolute fracture risk, i.e. the probability of sustaining a fracture during a given timeframe, will not only be more appealing to physicians but also more accessible to patients than the abstract T-score value of a DXA measurement. Ten-year absolute fracture probability data by gender, age and femoral neck T-score categories are herewith available for Switzerland. A recently published analysis of nine prospective population-based epidemiological studies from the USA, Europe, Australia and Asia, comprising 46,340 men and women followed for approximately 190,000 person-years in which 4,168 osteoporotic fractures were reported, allowed the identification of the following additional clinical risk factors for fractures: BMI, prior fragility fracture, parental history of hip fracture, current tobacco smoking, ever long-term use of glucocorticoids, rheumatoid arthritis, other causes of secondary osteoporosis and alcohol consumption of three or more units daily [12] . These data, which are generally usable throughout the world combined with the present results and which are specific for Incidenceof major osteoporotic fractures (per 100'000) Incidenceof major osteoporotic fractures (per 100'000) Fig. 4 Comparative incidence of major osteoporotic fractures (hip, spine, distal radius and proximal humerus) in number of fractures per 100,000 inhabitants Switzerland and other high-risk countries, will allow for the development of a fracture risk assessment tool (FRAX®), as it has already been published for the UK, the US and Japan [4, 11, 14] with the aim of identifying those patients in the low BMD range (T-score −1 to −2.5 SD) who have the highest risk of fracture and would potentially benefit from treatment. Even if BMD alone were shown to outperform the clinical risk factors for predicting fracture risk at all ages [12] , a significant percentage of the osteoporotic fractures occur in patients who do not meet the WHO T-score threshold of −2.5 SD required by the authorities in many countries for reimbursement of drug therapy aiming at preventing the first or subsequent fracture [16, 41] . The present data, and even more so, once interpolated with all identified clinical risk factors for FRAX®, will contribute to improving the predictive value of BMD measurements for fracture risk prediction [12] .
One strength of the present analysis is its internal consistency with the use of Swiss national epidemiological data, whenever possible. Several assumptions (see "Methods") were required to ensure the present validation process of FRAX® for Switzerland. It was assumed that BMD distribution at the femoral neck in Switzerland will be similar to that in the US NHANES III cohort [7, 18] . This assumption can be considered as robust. In a representative population of 400 Caucasian women and men, 20-80 years of age living in the area of Berne, the distribution of the BMD values at the femoral neck was compared to that of NHANES III (data not shown). This population had already served as the reference population in clinical trials published earlier [42] . Furthermore, it was assumed that the BMD gradient of risk will be the same as reported in the population-based cohorts used for the FRAX® algorithm [7] . For the latter, the Swiss SEMOF cohort [43] was used as a validation cohort [12] , which reinforces the validity of the assumption. However, in the present study, the interpolation with the BMD T-score categories relied on the published NHANES III data at the femoral neck only. Whether the same conclusions would apply by using BMD values measured by DXA at other sites, established by using other BMD measurement devices than DXA, such as ultrasound or peripheral QCT, and/or by using a normative database for femoral neck T scores other than NHANES III, cannot be answered by this study.
In conclusion, the present study validated the elements required for the development of a FRAX® model for use in Switzerland. It shows that Switzerland belongs to the high end of the spectrum of risk for osteoporotic fractures and that the burden of disease is comparable to that of cardiovascular diseases and cancer. The future determination of the individual fracture risk based on a more encompassing clinical risk factor profile will aid in identifying those patients who will benefit most from fracture prevention measures.
